JMN Financial’s Medtronic MDT Stock Holding History

JMN Financial’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,552	Closed	-$223K	–	249
2026 Q1	$223K	Sell	2,552 -572	-18%	-$54.8K	0.22%	156
2025 Q4	$303K	Buy	+3,124	New	+$303K	0.3%	108

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JMN Financial's MDT Position: Q2 2026 in Review

JMN Financial sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,552 shares — an estimated $223K sold.

JMN Financial first reported a position in MDT in Q4 2025 and held it in 2 quarters. The position peaked at $303K in Q4 2025. 2,044 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

JMN Financial reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
JMN Financial sold 2,552 Medtronic shares in Q2 2026, an estimated $223K.
JMN Financial first reported a position in Medtronic in Q4 2025 and held it in 2 quarters.
JMN Financial's Medtronic position peaked at $303K in Q4 2025.
2,044 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on JMN Financial's 13F filing for Q2 2026, filed 10 Aug 2026.